A physician has a choice in benzodiazepines to prescribe for patients. A particular patient (a 53-year-old man with anxiety) has a difficult time with compliance to medications. The physician is concerned about the patient going into withdrawal because of abrupt discontinuation of the antianxiety medication. Which of the following medications would have the least severe withdrawal reaction?

Correct Answer: A

Rationale: Diazepam has a long half-life, which reduces the risk of severe withdrawal symptoms compared to shorter-acting benzodiazepines like triazolam.

Correct Answer: C

Rationale: Many general anesthetics inhibit glutamate (excitatory neurotransmitter) to produce sedation and anesthesia.

Correct Answer: C

Rationale: Thromboxane A2 is a potent vasoconstrictor and platelet aggregator, playing a key role in clot formation.

Correct Answer: B

Rationale: Darifenacin, a muscarinic receptor antagonist used for urinary tract infections, may enhance the action of vecuronium by reducing the risk of cholinergic side effects, such as bradycardia or bronchoconstriction, associated with muscle relaxants. Gentamicin, Timolol, Latanoprost, and Lovastatin are unlikely to have a significant impact on the action of vecuronium in this context.

Correct Answer: C

Rationale: The correct answer is C: Cyclobenzaprine. Cyclobenzaprine is a centrally acting muscle relaxant commonly used to treat muscle spasticity in conditions like multiple sclerosis. It works by inhibiting nerve impulses to reduce muscle spasms. Neostigmine (A) is a cholinesterase inhibitor used for myasthenia gravis, not spasticity. Ropinirole (B) is a dopamine agonist used for Parkinson's disease and restless legs syndrome, not spasticity. Pyridostigmine (D) is also a cholinesterase inhibitor used for myasthenia gravis, not spasticity.